• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch + Lomb Corporation Common Shares (NY:BLCO)

    17.39 -0.19 (-1.08%)
    Streaming Delayed Price Updated: 12:39 PM EDT, Sep 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 110,066
    Open 17.65
    Bid (Size) 17.37 (100)
    Ask (Size) 17.40 (200)
    Prev. Close 17.58
    Today's Range 17.30 - 17.65
    52wk Range 13.77 - 18.91
    Shares Outstanding 353,800,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
    Via StockStory

    Performance

    YTD
    +4.9%
    +4.9%
    1 Month
    +2.3%
    +2.3%
    3 Month
    +15.9%
    +15.9%
    6 Month
    +5.5%
    +5.5%
    1 Year
    +14.2%
    +14.2%

    More News

    Read More
    News headline image
    Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
    Via StockStory
    News headline image
    3 Healthcare Stocks We Steer Clear Of
    Via StockStory
    News headline image
    Bausch + Lomb Advances Two Eye Therapies With Blockbuster Sales Potential ↗
    Via Benzinga
    News headline image
    A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q2 Earnings: Bausch + Lomb (NYSE:BLCO) Vs The Rest Of The Pack
    Via StockStory
    News headline image
    Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal ↗
    Via MarketBeat
    News headline image
    Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    3 Stocks Under $50 We’re Skeptical Of
    Via StockStory
    News headline image
    Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Bausch + Lomb (BLCO) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Bausch + Lomb (NYSE:BLCO) Exceeds Q2 CY2026 Expectations
    Via StockStory
    News headline image
    Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Reasons to Avoid BLCO and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks
    News headline image
    Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today
    Via StockStory
    Topics Artificial Intelligence Economy Initial Public Offering
    News headline image
    Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
    From Bausch + Lomb
    Via Business Wire
    News headline image
    Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
    From Bausch + Lomb
    Via Business Wire
    News headline image
    Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    1 Unpopular Stock That Deserves a Second Chance and 2 We Brush Off
    Via StockStory

    Frequently Asked Questions

    Is Bausch + Lomb Corporation Common Shares publicly traded?
    Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
    What exchange does Bausch + Lomb Corporation Common Shares trade on?
    Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
    What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
    The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
    What is the current price of Bausch + Lomb Corporation Common Shares?
    The current price of Bausch + Lomb Corporation Common Shares is 17.39
    When was Bausch + Lomb Corporation Common Shares last traded?
    The last trade of Bausch + Lomb Corporation Common Shares was at 09/15/26 12:39 PM ET
    What is the market capitalization of Bausch + Lomb Corporation Common Shares?
    The market capitalization of Bausch + Lomb Corporation Common Shares is 6.15B
    How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
    Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.